Use of Aortic Balloon Occlusion to Decrease Blood Loss During Sacral Tumor Resection

2010 ◽  
Vol 92 (8) ◽  
pp. 1747-1753 ◽  
Author(s):  
Xiaodong Tang ◽  
Wei Guo ◽  
Rongli Yang ◽  
Shun Tang ◽  
Sen Dong
2018 ◽  
Vol 476 (3) ◽  
pp. 490-498 ◽  
Author(s):  
Yidan Zhang ◽  
Wei Guo ◽  
Xiaodong Tang ◽  
Rongli Yang ◽  
Taiqiang Yan ◽  
...  

2021 ◽  
Vol 9 (5) ◽  
pp. 416-416
Author(s):  
Yi Luo ◽  
Mingyan Jiang ◽  
Jianguo Fang ◽  
Li Min ◽  
Yong Zhou ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Baoju Zhu ◽  
Kaili Yang ◽  
Lina Cai

Objective. This paper is aimed at investigating the role and value of the timing of balloon occlusion of the abdominal aorta during caesarean section in patients with pernicious placenta previa complicated with placenta accreta. Methods. 79 cases admitted to the Second Affiliated Hospital of Zhengzhou University from September 2015 to December 2016 were treated with ultrasound mediated abdominal aortic balloon occlusion. Among them, 42 cases, whose balloon occlusion time was selected before the delivery and transverse incision was taken, were group A. The other 37 cases were group B, whose timing of balloon occlusion was selected after the delivery and the uterine incision made trying to avoid the placenta or double incisions. The intraoperative blood loss, utilization of blood, and other indicators were compared between the two groups. Results. The intraoperative blood loss in groups A and B was 413.8 ± 105.9 ml and 810.3 ± 180.3 ml, and the utilization of blood products in groups A and B was 30.23% and 89.2%. The total hysterectomy rate was 2.53% (2/79), with no hysterectomies in groups A and 2 cases in group B. Conclusion. The balloon occlusion of the abdominal aorta before the delivery combined with a transverse incision is more effective.


2007 ◽  
Vol 105 (3) ◽  
pp. 700-703 ◽  
Author(s):  
Lan Zhang ◽  
Quan Gong ◽  
Hong Xiao ◽  
Chongqi Tu ◽  
Jin Liu

2008 ◽  
Vol 467 (6) ◽  
pp. 1599-1604 ◽  
Author(s):  
Xiaodong Tang ◽  
Wei Guo ◽  
Rongli Yang ◽  
Shun Tang ◽  
Tao Ji

2020 ◽  
Author(s):  
Hong Zhao ◽  
Yingchao Song ◽  
Sen Dong ◽  
Yi Feng

Abstract Background Sacrum tumor resection is with high morbidity due to complex anatomy, sacral nerves involvement, massive bleeding and tumor malignancy. Risk factors related with complications following sacrectomy were not clearly defined.Method Anesthetic database of Peking University People’s Hospital, Beijing, China was searched for all patients (aged 14-70 years of age) received sacrum tumor surgery from 2014 to 2017. As part of the bleeding control program, intra-aortic balloon occlusion (IABO) was applied to patients whose tumor volume was more than 200 cm3, a tumor that had invaded cephalad to the S2-S3 disc space, or tumor with an abundant blood supply. Results Finally 355 patients who underwent sacrectomy were included in this study, among whom 278 patients received intraoperative IABO, whose duration of aortic occlusion was 72±33 min. Extensive hemorrhage (>2000 ml) occurred in 61(21.9%) patients receiving IABO. Fifty-six patients in IABO Group required postoperative debridement due to wound infection. The independent risk factor identified by logistic regression was fluid excess (calculated as volume infused (crystalloid, colloid, CRC and FFP), minus blood loss and urine output, divided by body weight (kg)), and decision tree analysis found that the cut-off point for fluid excess was 38.5 ml/kg. Then propensity score matching of intraoperative blood loss and aortic occlusion duration was adopted for patients whose fluid excess >38.5 ml/kg and those whose was lower or equal. Afterwards, 91 pairs of patients were generated. Fluid excess was significantly different (46 vs. 30 ml/kg, P=0.000) for patients whose fluid excess was >38.5 ml/kg, and required more postoperative debridement (24 (26.3%) vs. 12 (13.1%), P=0.000) than those whose was lower or equal. Conclusion In this retrospective cohort study about sacrum tumor resection, duration of aortic occlusion and anesthesia were identified as predictors for massive bleeding. Fluid overload was related with high morbidity and studies are needed to further improve clinical prognosis.


2019 ◽  
Author(s):  
Zhongmei Yang ◽  
Jie Mei ◽  
Yan Hou ◽  
Qinyin Deng ◽  
Mengwei Huang ◽  
...  

Abstract Background Placenta increta or percreta will result in severe postpartum hemorrhage and become a research hotspot in obstetrics. Preoperative abdominal aortic balloon occlusion (AABO), as a new intravascular interventional therapy, has taken more and more attention in obstetrics. Thus, the aim of this study is to evaluate the safety and efficacy of abdominal aortic balloon occlusion. Methods Retrospective analysis of pregnant women with placenta increta or percreta delivered between January 2013 and April 2019 in the Sichuan Provincial People’s Hospital. The experimental group (AABO group) included 168 patients who underwent abdominal aortic balloon occlusion before cesarean section. The control group (NO-AABO group) was composed of 106 patients who underwent surgery without any preoperative intravascular interventional therapy. The parameters containing estimated blood loss, red cell suspension (RCS) transfusion volume, hysterectomy, surgery time, postoperative hospital days, neonatal status and complications were compared between the two groups. Results The patients with preoperative abdominal aortic balloon occlusion had significant reduction in blood loss volume, red cell suspension transfusion volume and plasma transfusion volume compared to patients without balloon. Similarly, the surgery time and hysterectomy were obviously reduced in AABO group. However, there were no differences in the Apgar scores and neonatal complications between the two groups, indicating that the abdominal aortic balloon has little adverse effect on the newborns. Conclusion AABO is a safe and effective technology for pregnant women with placenta increta or percreta to reduce blood loss volume and blood transfusion volume.


Author(s):  
Igor M. Samokhvalov

Dear Readers, Welcome to the sixth edition of the JEVTM! In 1866, the Great Russian surgeon and scientist Nikolai Pirogov wrote: “A new era for surgery will begin, if we can quickly and surely control the flow in a major artery without exploration and ligation”. This era has now arrived and it is called EVTM! Our mission has been to maximize the benefits of endovascular technologies for trauma and bleeding patients: from the first attempts of REBOA by Carl Hughes in the 1950s with hand-made aortic balloon occlusion catheters used in our department since the early 1990s to modern successful cases of out-of-hospital REBOA use in combat and civilian casualties for ruptured aneurysms, post-partum hemorrhage and trauma. In this edition, you will find articles related to a new strategy of damage control interventional radiology (DCIR), partial REBOA in elderly patients and in ruptured aortic aneurysms, thrombolysis for trauma-associated IVC thrombosis, simulation models for training of REBOA, contemporary utilization of Zone III REBOA and more. As a continuation of EVTM development, Russian surgeons, emergency physicians, anesthetists, and others will be involved in the world of EVTM, participating in expanding the horizons of trauma care and cultivating the endovascular mindset. Also published in this edition are some of the abstracts that will be presented at the EVTM conference in Russia, St. Petersburg (7/06/2019). More than 35 oral and 30 poster presentations will make this conference a scientific feast for our audience! By adopting these new techniques for bleeding management, we are following Pirogov’s motto – to achieve fast endovascular hemorrhage control – which can only be done as part of an interdisciplinary approach.   We look forward to seeing you in Saint Petersburg at the EVTM-Russia meeting! www.evtm.org


Sign in / Sign up

Export Citation Format

Share Document